nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Quinine—CYP2E1—liver cancer	0.00851	0.221	CrCbGaD
Quinidine barbiturate—Quinine—CYP1A1—liver cancer	0.0084	0.218	CrCbGaD
Quinidine barbiturate—Quinidine—CYP2E1—liver cancer	0.00748	0.194	CrCbGaD
Quinidine barbiturate—Quinidine—CYP1A1—liver cancer	0.00738	0.192	CrCbGaD
Quinidine barbiturate—Vasodilation—Doxorubicin—liver cancer	0.00354	0.0038	CcSEcCtD
Quinidine barbiturate—Vasodilation procedure—Doxorubicin—liver cancer	0.00354	0.0038	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Sorafenib—liver cancer	0.00349	0.00376	CcSEcCtD
Quinidine barbiturate—Atrioventricular block—Epirubicin—liver cancer	0.00346	0.00372	CcSEcCtD
Quinidine barbiturate—Bone disorder—Doxorubicin—liver cancer	0.00344	0.0037	CcSEcCtD
Quinidine barbiturate—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00344	0.0037	CcSEcCtD
Quinidine barbiturate—Thinking abnormal—Doxorubicin—liver cancer	0.0034	0.00365	CcSEcCtD
Quinidine barbiturate—Hypocalcaemia—Doxorubicin—liver cancer	0.0034	0.00365	CcSEcCtD
Quinidine barbiturate—Phenobarbital—CYP2E1—liver cancer	0.00339	0.088	CrCbGaD
Quinidine barbiturate—Myalgia—Sorafenib—liver cancer	0.00338	0.00364	CcSEcCtD
Quinidine barbiturate—Arthralgia—Sorafenib—liver cancer	0.00338	0.00364	CcSEcCtD
Quinidine barbiturate—Oliguria—Doxorubicin—liver cancer	0.00337	0.00363	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00336	0.00361	CcSEcCtD
Quinidine barbiturate—Hepatocellular injury—Epirubicin—liver cancer	0.00336	0.00361	CcSEcCtD
Quinidine barbiturate—Ventricular tachycardia—Epirubicin—liver cancer	0.00336	0.00361	CcSEcCtD
Quinidine barbiturate—Phenobarbital—CYP1A1—liver cancer	0.00334	0.0868	CrCbGaD
Quinidine barbiturate—Injection site reaction—Epirubicin—liver cancer	0.00334	0.00359	CcSEcCtD
Quinidine barbiturate—Dermatitis contact—Epirubicin—liver cancer	0.00332	0.00357	CcSEcCtD
Quinidine barbiturate—Atrioventricular block—Doxorubicin—liver cancer	0.00321	0.00345	CcSEcCtD
Quinidine barbiturate—Shock—Sorafenib—liver cancer	0.00319	0.00343	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Sorafenib—liver cancer	0.00318	0.00342	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Sorafenib—liver cancer	0.00318	0.00341	CcSEcCtD
Quinidine barbiturate—Aplastic anaemia—Epirubicin—liver cancer	0.00316	0.00339	CcSEcCtD
Quinidine barbiturate—Skin disorder—Sorafenib—liver cancer	0.00315	0.00339	CcSEcCtD
Quinidine barbiturate—Ventricular tachycardia—Doxorubicin—liver cancer	0.00311	0.00334	CcSEcCtD
Quinidine barbiturate—Hepatocellular injury—Doxorubicin—liver cancer	0.00311	0.00334	CcSEcCtD
Quinidine barbiturate—Anorexia—Sorafenib—liver cancer	0.00309	0.00332	CcSEcCtD
Quinidine barbiturate—Injection site reaction—Doxorubicin—liver cancer	0.00309	0.00332	CcSEcCtD
Quinidine barbiturate—Dermatitis contact—Doxorubicin—liver cancer	0.00307	0.0033	CcSEcCtD
Quinidine barbiturate—Coma—Epirubicin—liver cancer	0.00307	0.0033	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Epirubicin—liver cancer	0.00307	0.0033	CcSEcCtD
Quinidine barbiturate—Ecchymosis—Epirubicin—liver cancer	0.00304	0.00327	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Epirubicin—liver cancer	0.00299	0.00322	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00296	0.00318	CcSEcCtD
Quinidine barbiturate—Aplastic anaemia—Doxorubicin—liver cancer	0.00292	0.00314	CcSEcCtD
Quinidine barbiturate—Mental disability—Epirubicin—liver cancer	0.00292	0.00314	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Sorafenib—liver cancer	0.00289	0.00311	CcSEcCtD
Quinidine barbiturate—Coma—Doxorubicin—liver cancer	0.00284	0.00305	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Doxorubicin—liver cancer	0.00284	0.00305	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Sorafenib—liver cancer	0.00282	0.00303	CcSEcCtD
Quinidine barbiturate—Ecchymosis—Doxorubicin—liver cancer	0.00281	0.00302	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Sorafenib—liver cancer	0.0028	0.00301	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Epirubicin—liver cancer	0.00278	0.00299	CcSEcCtD
Quinidine barbiturate—Pain—Sorafenib—liver cancer	0.00277	0.00298	CcSEcCtD
Quinidine barbiturate—Constipation—Sorafenib—liver cancer	0.00277	0.00298	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Doxorubicin—liver cancer	0.00277	0.00298	CcSEcCtD
Quinidine barbiturate—Eczema—Epirubicin—liver cancer	0.00271	0.00292	CcSEcCtD
Quinidine barbiturate—Mental disability—Doxorubicin—liver cancer	0.0027	0.0029	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Sorafenib—liver cancer	0.00265	0.00285	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Epirubicin—liver cancer	0.00264	0.00284	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Epirubicin—liver cancer	0.00259	0.00278	CcSEcCtD
Quinidine barbiturate—Urticaria—Sorafenib—liver cancer	0.00258	0.00277	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Doxorubicin—liver cancer	0.00257	0.00276	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Sorafenib—liver cancer	0.00256	0.00276	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Sorafenib—liver cancer	0.00256	0.00276	CcSEcCtD
Quinidine barbiturate—Renal impairment—Epirubicin—liver cancer	0.00256	0.00276	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Epirubicin—liver cancer	0.00255	0.00274	CcSEcCtD
Quinidine barbiturate—Purpura—Epirubicin—liver cancer	0.00253	0.00272	CcSEcCtD
Quinidine barbiturate—Eczema—Doxorubicin—liver cancer	0.00251	0.0027	CcSEcCtD
Quinidine barbiturate—Hypoglycaemia—Epirubicin—liver cancer	0.0025	0.00269	CcSEcCtD
Quinidine barbiturate—Lethargy—Epirubicin—liver cancer	0.00249	0.00268	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Doxorubicin—liver cancer	0.00244	0.00263	CcSEcCtD
Quinidine barbiturate—Diplopia—Epirubicin—liver cancer	0.00244	0.00262	CcSEcCtD
Quinidine barbiturate—Affect lability—Epirubicin—liver cancer	0.0024	0.00258	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00239	0.00257	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Sorafenib—liver cancer	0.00239	0.00257	CcSEcCtD
Quinidine barbiturate—Renal impairment—Doxorubicin—liver cancer	0.00237	0.00255	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Doxorubicin—liver cancer	0.00236	0.00254	CcSEcCtD
Quinidine barbiturate—Purpura—Doxorubicin—liver cancer	0.00234	0.00252	CcSEcCtD
Quinidine barbiturate—Asthenia—Sorafenib—liver cancer	0.00233	0.0025	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Epirubicin—liver cancer	0.00232	0.00249	CcSEcCtD
Quinidine barbiturate—Hypoglycaemia—Doxorubicin—liver cancer	0.00231	0.00249	CcSEcCtD
Quinidine barbiturate—Mood swings—Epirubicin—liver cancer	0.00231	0.00248	CcSEcCtD
Quinidine barbiturate—Lethargy—Doxorubicin—liver cancer	0.0023	0.00248	CcSEcCtD
Quinidine barbiturate—Pruritus—Sorafenib—liver cancer	0.0023	0.00247	CcSEcCtD
Quinidine barbiturate—Ataxia—Epirubicin—liver cancer	0.00229	0.00247	CcSEcCtD
Quinidine barbiturate—Diplopia—Doxorubicin—liver cancer	0.00226	0.00243	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Epirubicin—liver cancer	0.00225	0.00242	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Epirubicin—liver cancer	0.00223	0.0024	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Epirubicin—liver cancer	0.00223	0.0024	CcSEcCtD
Quinidine barbiturate—Affect lability—Doxorubicin—liver cancer	0.00222	0.00239	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Sorafenib—liver cancer	0.00222	0.00239	CcSEcCtD
Quinidine barbiturate—Breast disorder—Epirubicin—liver cancer	0.0022	0.00237	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.0022	0.00236	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Epirubicin—liver cancer	0.00215	0.00231	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Doxorubicin—liver cancer	0.00215	0.00231	CcSEcCtD
Quinidine barbiturate—Dizziness—Sorafenib—liver cancer	0.00215	0.00231	CcSEcCtD
Quinidine barbiturate—Mood swings—Doxorubicin—liver cancer	0.00214	0.0023	CcSEcCtD
Quinidine barbiturate—Ataxia—Doxorubicin—liver cancer	0.00212	0.00228	CcSEcCtD
Quinidine barbiturate—Asthma—Epirubicin—liver cancer	0.00211	0.00227	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Doxorubicin—liver cancer	0.00208	0.00224	CcSEcCtD
Quinidine barbiturate—Vomiting—Sorafenib—liver cancer	0.00206	0.00222	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Doxorubicin—liver cancer	0.00206	0.00222	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Doxorubicin—liver cancer	0.00206	0.00222	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Epirubicin—liver cancer	0.00205	0.00221	CcSEcCtD
Quinidine barbiturate—Rash—Sorafenib—liver cancer	0.00205	0.0022	CcSEcCtD
Quinidine barbiturate—Dermatitis—Sorafenib—liver cancer	0.00204	0.0022	CcSEcCtD
Quinidine barbiturate—Breast disorder—Doxorubicin—liver cancer	0.00204	0.00219	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00203	0.00219	CcSEcCtD
Quinidine barbiturate—Headache—Sorafenib—liver cancer	0.00203	0.00218	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Epirubicin—liver cancer	0.002	0.00215	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Doxorubicin—liver cancer	0.00199	0.00214	CcSEcCtD
Quinidine barbiturate—Neutropenia—Epirubicin—liver cancer	0.00197	0.00212	CcSEcCtD
Quinidine barbiturate—Asthma—Doxorubicin—liver cancer	0.00195	0.0021	CcSEcCtD
Quinidine barbiturate—Nausea—Sorafenib—liver cancer	0.00193	0.00207	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Epirubicin—liver cancer	0.00192	0.00207	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Doxorubicin—liver cancer	0.0019	0.00204	CcSEcCtD
Quinidine barbiturate—Drowsiness—Epirubicin—liver cancer	0.00188	0.00202	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00186	0.002	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Doxorubicin—liver cancer	0.00185	0.00199	CcSEcCtD
Quinidine barbiturate—Renal failure—Epirubicin—liver cancer	0.00185	0.00199	CcSEcCtD
Quinidine barbiturate—Jaundice—Epirubicin—liver cancer	0.00183	0.00197	CcSEcCtD
Quinidine barbiturate—Neutropenia—Doxorubicin—liver cancer	0.00182	0.00196	CcSEcCtD
Quinidine barbiturate—Sweating—Epirubicin—liver cancer	0.0018	0.00194	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Doxorubicin—liver cancer	0.00178	0.00191	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Epirubicin—liver cancer	0.00175	0.00189	CcSEcCtD
Quinidine barbiturate—Drowsiness—Doxorubicin—liver cancer	0.00174	0.00187	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00172	0.00185	CcSEcCtD
Quinidine barbiturate—Bradycardia—Epirubicin—liver cancer	0.00172	0.00185	CcSEcCtD
Quinidine barbiturate—Renal failure—Doxorubicin—liver cancer	0.00171	0.00184	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Epirubicin—liver cancer	0.0017	0.00182	CcSEcCtD
Quinidine barbiturate—Jaundice—Doxorubicin—liver cancer	0.0017	0.00182	CcSEcCtD
Quinidine barbiturate—Hepatitis—Epirubicin—liver cancer	0.00169	0.00181	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Epirubicin—liver cancer	0.00169	0.00181	CcSEcCtD
Quinidine barbiturate—Sweating—Doxorubicin—liver cancer	0.00167	0.00179	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Epirubicin—liver cancer	0.00167	0.00179	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Epirubicin—liver cancer	0.00165	0.00178	CcSEcCtD
Quinidine barbiturate—Visual impairment—Epirubicin—liver cancer	0.00163	0.00175	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Doxorubicin—liver cancer	0.00162	0.00175	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Epirubicin—liver cancer	0.0016	0.00172	CcSEcCtD
Quinidine barbiturate—Bradycardia—Doxorubicin—liver cancer	0.00159	0.00171	CcSEcCtD
Quinidine barbiturate—Eye disorder—Epirubicin—liver cancer	0.00158	0.0017	CcSEcCtD
Quinidine barbiturate—Tinnitus—Epirubicin—liver cancer	0.00157	0.00169	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—liver cancer	0.00157	0.00169	CcSEcCtD
Quinidine barbiturate—Flushing—Epirubicin—liver cancer	0.00157	0.00168	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Epirubicin—liver cancer	0.00157	0.00168	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—liver cancer	0.00156	0.00168	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—liver cancer	0.00156	0.00168	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—liver cancer	0.00154	0.00166	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—liver cancer	0.00153	0.00165	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Epirubicin—liver cancer	0.00152	0.00164	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Epirubicin—liver cancer	0.00152	0.00164	CcSEcCtD
Quinidine barbiturate—Chills—Epirubicin—liver cancer	0.00151	0.00163	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—liver cancer	0.0015	0.00162	CcSEcCtD
Quinidine barbiturate—Mental disorder—Epirubicin—liver cancer	0.00148	0.00159	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—liver cancer	0.00148	0.00159	CcSEcCtD
Quinidine barbiturate—Erythema—Epirubicin—liver cancer	0.00147	0.00158	CcSEcCtD
Quinidine barbiturate—Malnutrition—Epirubicin—liver cancer	0.00147	0.00158	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—liver cancer	0.00146	0.00157	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—liver cancer	0.00146	0.00157	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—liver cancer	0.00145	0.00156	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—liver cancer	0.00145	0.00156	CcSEcCtD
Quinidine barbiturate—Tension—Epirubicin—liver cancer	0.00144	0.00155	CcSEcCtD
Quinidine barbiturate—Nervousness—Epirubicin—liver cancer	0.00143	0.00153	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—liver cancer	0.00141	0.00152	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—liver cancer	0.00141	0.00151	CcSEcCtD
Quinidine barbiturate—Chills—Doxorubicin—liver cancer	0.0014	0.00151	CcSEcCtD
Quinidine barbiturate—Vision blurred—Epirubicin—liver cancer	0.00138	0.00149	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—liver cancer	0.00137	0.00147	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—liver cancer	0.00136	0.00146	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—liver cancer	0.00136	0.00146	CcSEcCtD
Quinidine barbiturate—Agitation—Epirubicin—liver cancer	0.00135	0.00145	CcSEcCtD
Quinidine barbiturate—Tension—Doxorubicin—liver cancer	0.00133	0.00143	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—liver cancer	0.00132	0.00142	CcSEcCtD
Quinidine barbiturate—Vertigo—Epirubicin—liver cancer	0.00132	0.00142	CcSEcCtD
Quinidine barbiturate—Syncope—Epirubicin—liver cancer	0.00132	0.00142	CcSEcCtD
Quinidine barbiturate—Leukopenia—Epirubicin—liver cancer	0.00132	0.00141	CcSEcCtD
Quinidine barbiturate—Palpitations—Epirubicin—liver cancer	0.0013	0.0014	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Epirubicin—liver cancer	0.00129	0.00139	CcSEcCtD
Quinidine barbiturate—Vision blurred—Doxorubicin—liver cancer	0.00128	0.00138	CcSEcCtD
Quinidine barbiturate—Convulsion—Epirubicin—liver cancer	0.00127	0.00137	CcSEcCtD
Quinidine barbiturate—Arthralgia—Epirubicin—liver cancer	0.00125	0.00134	CcSEcCtD
Quinidine barbiturate—Chest pain—Epirubicin—liver cancer	0.00125	0.00134	CcSEcCtD
Quinidine barbiturate—Myalgia—Epirubicin—liver cancer	0.00125	0.00134	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—liver cancer	0.00125	0.00134	CcSEcCtD
Quinidine barbiturate—Anxiety—Epirubicin—liver cancer	0.00125	0.00134	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00124	0.00134	CcSEcCtD
Quinidine barbiturate—Vertigo—Doxorubicin—liver cancer	0.00122	0.00131	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—liver cancer	0.00122	0.00131	CcSEcCtD
Quinidine barbiturate—Leukopenia—Doxorubicin—liver cancer	0.00122	0.00131	CcSEcCtD
Quinidine barbiturate—Confusional state—Epirubicin—liver cancer	0.00121	0.0013	CcSEcCtD
Quinidine barbiturate—Palpitations—Doxorubicin—liver cancer	0.0012	0.00129	CcSEcCtD
Quinidine barbiturate—Oedema—Epirubicin—liver cancer	0.0012	0.00129	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—liver cancer	0.00119	0.00128	CcSEcCtD
Quinidine barbiturate—Shock—Epirubicin—liver cancer	0.00118	0.00127	CcSEcCtD
Quinidine barbiturate—Convulsion—Doxorubicin—liver cancer	0.00118	0.00127	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Epirubicin—liver cancer	0.00118	0.00126	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Epirubicin—liver cancer	0.00117	0.00126	CcSEcCtD
Quinidine barbiturate—Tachycardia—Epirubicin—liver cancer	0.00117	0.00126	CcSEcCtD
Quinidine barbiturate—Skin disorder—Epirubicin—liver cancer	0.00116	0.00125	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Epirubicin—liver cancer	0.00116	0.00125	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—liver cancer	0.00116	0.00124	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—liver cancer	0.00116	0.00124	CcSEcCtD
Quinidine barbiturate—Myalgia—Doxorubicin—liver cancer	0.00116	0.00124	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—liver cancer	0.00115	0.00124	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00115	0.00124	CcSEcCtD
Quinidine barbiturate—Anorexia—Epirubicin—liver cancer	0.00114	0.00123	CcSEcCtD
Quinidine barbiturate—Hypotension—Epirubicin—liver cancer	0.00112	0.0012	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—liver cancer	0.00112	0.0012	CcSEcCtD
Quinidine barbiturate—Oedema—Doxorubicin—liver cancer	0.00111	0.00119	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00109	0.00117	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—liver cancer	0.00109	0.00117	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—liver cancer	0.00109	0.00117	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—liver cancer	0.00109	0.00117	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—liver cancer	0.00108	0.00116	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—liver cancer	0.00108	0.00116	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—liver cancer	0.00107	0.00115	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Epirubicin—liver cancer	0.00107	0.00115	CcSEcCtD
Quinidine barbiturate—Somnolence—Epirubicin—liver cancer	0.00107	0.00115	CcSEcCtD
Quinidine barbiturate—Anorexia—Doxorubicin—liver cancer	0.00106	0.00114	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Epirubicin—liver cancer	0.00104	0.00112	CcSEcCtD
Quinidine barbiturate—Hypotension—Doxorubicin—liver cancer	0.00104	0.00111	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Epirubicin—liver cancer	0.00104	0.00111	CcSEcCtD
Quinidine barbiturate—Constipation—Epirubicin—liver cancer	0.00103	0.0011	CcSEcCtD
Quinidine barbiturate—Pain—Epirubicin—liver cancer	0.00103	0.0011	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00101	0.00109	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Doxorubicin—liver cancer	0.000989	0.00106	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Epirubicin—liver cancer	0.000988	0.00106	CcSEcCtD
Quinidine barbiturate—Somnolence—Doxorubicin—liver cancer	0.000986	0.00106	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Epirubicin—liver cancer	0.00098	0.00105	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—liver cancer	0.000964	0.00104	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000958	0.00103	CcSEcCtD
Quinidine barbiturate—Urticaria—Epirubicin—liver cancer	0.000952	0.00102	CcSEcCtD
Quinidine barbiturate—Constipation—Doxorubicin—liver cancer	0.000949	0.00102	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—liver cancer	0.000949	0.00102	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Epirubicin—liver cancer	0.000948	0.00102	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Epirubicin—liver cancer	0.000948	0.00102	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—liver cancer	0.000914	0.000983	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000907	0.000975	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Epirubicin—liver cancer	0.000883	0.00095	CcSEcCtD
Quinidine barbiturate—Urticaria—Doxorubicin—liver cancer	0.000881	0.000947	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—liver cancer	0.000877	0.000943	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Doxorubicin—liver cancer	0.000877	0.000943	CcSEcCtD
Quinidine barbiturate—Asthenia—Epirubicin—liver cancer	0.00086	0.000925	CcSEcCtD
Quinidine barbiturate—Pruritus—Epirubicin—liver cancer	0.000848	0.000912	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Epirubicin—liver cancer	0.00082	0.000882	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—liver cancer	0.000817	0.000879	CcSEcCtD
Quinidine barbiturate—Asthenia—Doxorubicin—liver cancer	0.000796	0.000856	CcSEcCtD
Quinidine barbiturate—Dizziness—Epirubicin—liver cancer	0.000793	0.000852	CcSEcCtD
Quinidine barbiturate—Pruritus—Doxorubicin—liver cancer	0.000785	0.000844	CcSEcCtD
Quinidine barbiturate—Vomiting—Epirubicin—liver cancer	0.000762	0.00082	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Doxorubicin—liver cancer	0.000759	0.000816	CcSEcCtD
Quinidine barbiturate—Rash—Epirubicin—liver cancer	0.000756	0.000813	CcSEcCtD
Quinidine barbiturate—Dermatitis—Epirubicin—liver cancer	0.000755	0.000812	CcSEcCtD
Quinidine barbiturate—Headache—Epirubicin—liver cancer	0.000751	0.000807	CcSEcCtD
Quinidine barbiturate—Dizziness—Doxorubicin—liver cancer	0.000734	0.000789	CcSEcCtD
Quinidine barbiturate—Nausea—Epirubicin—liver cancer	0.000712	0.000766	CcSEcCtD
Quinidine barbiturate—Vomiting—Doxorubicin—liver cancer	0.000705	0.000758	CcSEcCtD
Quinidine barbiturate—Rash—Doxorubicin—liver cancer	0.000699	0.000752	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—liver cancer	0.000699	0.000751	CcSEcCtD
Quinidine barbiturate—Headache—Doxorubicin—liver cancer	0.000695	0.000747	CcSEcCtD
Quinidine barbiturate—Nausea—Doxorubicin—liver cancer	0.000659	0.000708	CcSEcCtD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.000111	0.00356	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000111	0.00355	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000111	0.00355	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MTOR—liver cancer	0.000111	0.00354	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HNF4A—liver cancer	0.000109	0.00349	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—HRAS—liver cancer	0.000108	0.00344	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000105	0.00337	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000105	0.00336	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000104	0.00334	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000104	0.00334	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000104	0.00333	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000104	0.00331	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000103	0.00329	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CASP3—liver cancer	0.000102	0.00326	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000102	0.00325	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCE—liver cancer	9.95e-05	0.00318	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—JUN—liver cancer	9.89e-05	0.00316	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC40A1—liver cancer	9.89e-05	0.00316	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ABL1—liver cancer	9.86e-05	0.00315	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CTNNB1—liver cancer	9.82e-05	0.00314	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTA1—liver cancer	9.81e-05	0.00314	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	9.78e-05	0.00313	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—NAT2—liver cancer	9.7e-05	0.0031	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	9.57e-05	0.00306	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	9.54e-05	0.00305	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ANXA2—liver cancer	9.48e-05	0.00303	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ATP7B—liver cancer	9.48e-05	0.00303	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MAPK8—liver cancer	9.36e-05	0.00299	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—NR1H4—liver cancer	8.97e-05	0.00287	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—RAF1—liver cancer	8.72e-05	0.00279	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CASP3—liver cancer	8.71e-05	0.00278	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—STAT3—liver cancer	8.56e-05	0.00273	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	8.55e-05	0.00273	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—JUN—liver cancer	8.46e-05	0.0027	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CASP3—liver cancer	8.44e-05	0.0027	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—liver cancer	8.39e-05	0.00268	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	8.34e-05	0.00267	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—JUN—liver cancer	8.2e-05	0.00262	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	8.17e-05	0.00261	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	8.14e-05	0.0026	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CTNNB1—liver cancer	8.14e-05	0.0026	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—BRAF—liver cancer	8e-05	0.00256	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—HPGDS—liver cancer	7.76e-05	0.00248	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KDR—liver cancer	7.47e-05	0.00239	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—VEGFA—liver cancer	7.39e-05	0.00236	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BRAF—liver cancer	7.36e-05	0.00235	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MET—liver cancer	7.31e-05	0.00234	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Ion channel transport—RAF1—liver cancer	7.27e-05	0.00232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR4—liver cancer	7.27e-05	0.00232	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—VEGFA—liver cancer	7.16e-05	0.00229	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—BRAF—liver cancer	7.07e-05	0.00226	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ABL1—liver cancer	7.04e-05	0.00225	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	6.97e-05	0.00223	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—F2—liver cancer	6.91e-05	0.00221	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—RAF1—liver cancer	6.68e-05	0.00214	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—APC—liver cancer	6.61e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—liver cancer	6.61e-05	0.00211	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	6.39e-05	0.00204	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—liver cancer	6.33e-05	0.00202	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP2E1—liver cancer	6.32e-05	0.00202	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BRAF—liver cancer	6.27e-05	0.002	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—HRAS—liver cancer	6.25e-05	0.002	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	6.24e-05	0.00199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—liver cancer	6.21e-05	0.00199	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ion channel transport—RAF1—liver cancer	6.2e-05	0.00198	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—RAF1—liver cancer	6.14e-05	0.00196	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—liver cancer	6.14e-05	0.00196	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP2—liver cancer	6.1e-05	0.00195	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—RAF1—liver cancer	5.9e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—liver cancer	5.81e-05	0.00186	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GGT1—liver cancer	5.81e-05	0.00186	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CASP3—liver cancer	5.74e-05	0.00183	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARA—liver cancer	5.74e-05	0.00183	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BRAF—liver cancer	5.64e-05	0.0018	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—JUN—liver cancer	5.57e-05	0.00178	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CHN2—liver cancer	5.53e-05	0.00177	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	5.53e-05	0.00177	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—AKT1—liver cancer	5.52e-05	0.00176	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—RAF1—liver cancer	5.4e-05	0.00173	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CYCS—liver cancer	5.36e-05	0.00171	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KDR—liver cancer	5.33e-05	0.0017	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK14—liver cancer	5.3e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—RAF1—liver cancer	5.24e-05	0.00167	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MET—liver cancer	5.22e-05	0.00167	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTP1—liver cancer	5.21e-05	0.00167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—RAF1—liver cancer	5.19e-05	0.00166	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	5.14e-05	0.00164	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL6—liver cancer	5.11e-05	0.00163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—liver cancer	5.07e-05	0.00162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IFT88—liver cancer	5.06e-05	0.00162	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL6—liver cancer	4.95e-05	0.00158	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—VEGFA—liver cancer	4.87e-05	0.00156	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BRAF—liver cancer	4.81e-05	0.00154	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—HRAS—liver cancer	4.8e-05	0.00153	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTM1—liver cancer	4.79e-05	0.00153	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARG—liver cancer	4.74e-05	0.00152	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	4.73e-05	0.00151	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—RAF1—liver cancer	4.71e-05	0.0015	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—HMOX1—liver cancer	4.66e-05	0.00149	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MMP9—liver cancer	4.59e-05	0.00147	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	4.57e-05	0.00146	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP1A1—liver cancer	4.54e-05	0.00145	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	4.5e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—liver cancer	4.49e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	4.48e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—JUN—liver cancer	4.36e-05	0.00139	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP2—liver cancer	4.35e-05	0.00139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—liver cancer	4.33e-05	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TRIO—liver cancer	4.28e-05	0.00137	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	4.17e-05	0.00133	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—liver cancer	4.12e-05	0.00132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR4—liver cancer	4.11e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—RAF1—liver cancer	4.01e-05	0.00128	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.97e-05	0.00127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TRIO—liver cancer	3.89e-05	0.00124	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RAF1—liver cancer	3.86e-05	0.00123	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	3.84e-05	0.00123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	3.81e-05	0.00122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—liver cancer	3.81e-05	0.00122	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	3.76e-05	0.0012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR4—liver cancer	3.73e-05	0.00119	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—HRAS—liver cancer	3.68e-05	0.00118	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KRAS—liver cancer	3.5e-05	0.00112	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UGDH—liver cancer	3.4e-05	0.00109	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	3.38e-05	0.00108	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	3.37e-05	0.00108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—liver cancer	3.36e-05	0.00107	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNB1—liver cancer	3.34e-05	0.00107	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—liver cancer	3.27e-05	0.00105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—liver cancer	3.27e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—HRAS—liver cancer	3.25e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	3.21e-05	0.00103	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EPT1—liver cancer	3.19e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SHC3—liver cancer	3.1e-05	0.000991	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—liver cancer	3.09e-05	0.000987	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TAT—liver cancer	3.03e-05	0.000968	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—HRAS—liver cancer	2.98e-05	0.000951	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—liver cancer	2.94e-05	0.000939	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—STAT3—liver cancer	2.91e-05	0.00093	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—F2—liver cancer	2.9e-05	0.000928	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	2.88e-05	0.000921	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—liver cancer	2.85e-05	0.00091	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	2.8e-05	0.000894	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—liver cancer	2.7e-05	0.000862	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—liver cancer	2.64e-05	0.000842	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—HRAS—liver cancer	2.59e-05	0.000828	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	2.53e-05	0.000808	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—liver cancer	2.52e-05	0.000805	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—liver cancer	2.5e-05	0.000798	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FST—liver cancer	2.41e-05	0.00077	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	2.39e-05	0.000762	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCE—liver cancer	2.36e-05	0.000756	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TRIO—liver cancer	2.3e-05	0.000734	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—HRAS—liver cancer	2.21e-05	0.000706	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR4—liver cancer	2.2e-05	0.000704	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	2.16e-05	0.000689	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCE—liver cancer	2.15e-05	0.000686	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HRAS—liver cancer	2.12e-05	0.000678	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CSF2—liver cancer	2.09e-05	0.000668	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GLUL—liver cancer	2.06e-05	0.000658	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CPT1B—liver cancer	2.06e-05	0.000658	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—liver cancer	2.03e-05	0.000649	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NR1H4—liver cancer	1.99e-05	0.000634	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA3—liver cancer	1.95e-05	0.000624	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CSF2—liver cancer	1.9e-05	0.000607	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—liver cancer	1.87e-05	0.000599	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA4—liver cancer	1.78e-05	0.00057	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADAM17—liver cancer	1.74e-05	0.000556	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA2—liver cancer	1.74e-05	0.000556	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTA1—liver cancer	1.68e-05	0.000536	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NAT2—liver cancer	1.66e-05	0.00053	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—F2—liver cancer	1.64e-05	0.000525	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSMD10—liver cancer	1.64e-05	0.000523	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSMA4—liver cancer	1.64e-05	0.000523	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALDOB—liver cancer	1.59e-05	0.000508	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CG—liver cancer	1.57e-05	0.000502	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CRABP1—liver cancer	1.52e-05	0.000485	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—F2—liver cancer	1.49e-05	0.000476	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CG—liver cancer	1.43e-05	0.000456	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	1.38e-05	0.000441	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HPGDS—liver cancer	1.33e-05	0.000424	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCE—liver cancer	1.27e-05	0.000405	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	1.25e-05	0.000401	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	1.2e-05	0.000385	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—liver cancer	1.2e-05	0.000384	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PSMA4—liver cancer	1.18e-05	0.000378	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PSMD10—liver cancer	1.18e-05	0.000378	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GOT2—liver cancer	1.15e-05	0.000368	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CSF2—liver cancer	1.12e-05	0.000359	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAF1—liver cancer	1.12e-05	0.000358	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—H2AFX—liver cancer	1.11e-05	0.000353	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—liver cancer	1.11e-05	0.000353	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	1.09e-05	0.000349	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2E1—liver cancer	1.08e-05	0.000346	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYCS—liver cancer	1.01e-05	0.000323	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—liver cancer	1e-05	0.000321	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—liver cancer	1e-05	0.00032	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GOT1—liver cancer	9.93e-06	0.000317	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GGT1—liver cancer	9.93e-06	0.000317	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—liver cancer	9.15e-06	0.000292	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK14—liver cancer	9.09e-06	0.00029	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—liver cancer	8.92e-06	0.000285	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ESR1—liver cancer	8.92e-06	0.000285	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—F2—liver cancer	8.81e-06	0.000281	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMOX1—liver cancer	8.8e-06	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APC—liver cancer	8.43e-06	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CG—liver cancer	8.43e-06	0.000269	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—liver cancer	8.2e-06	0.000262	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—liver cancer	7.92e-06	0.000253	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1A1—liver cancer	7.77e-06	0.000248	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CD—liver cancer	7.41e-06	0.000237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	7.34e-06	0.000234	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SERPINE1—liver cancer	7.33e-06	0.000234	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—liver cancer	7.25e-06	0.000232	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—liver cancer	7.24e-06	0.000231	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARA—liver cancer	7.11e-06	0.000227	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	6.66e-06	0.000213	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAF1—liver cancer	6.61e-06	0.000211	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MTOR—liver cancer	6.46e-06	0.000206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CB—liver cancer	6.46e-06	0.000206	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HRAS—liver cancer	6.17e-06	0.000197	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CG—liver cancer	6.09e-06	0.000194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1B—liver cancer	6.06e-06	0.000194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—liver cancer	5.99e-06	0.000192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—liver cancer	5.94e-06	0.00019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—liver cancer	5.93e-06	0.00019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—liver cancer	5.9e-06	0.000189	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARG—liver cancer	5.87e-06	0.000188	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—liver cancer	5.78e-06	0.000185	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUN—liver cancer	5.77e-06	0.000184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNB1—liver cancer	5.73e-06	0.000183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—liver cancer	5.61e-06	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1A—liver cancer	5.59e-06	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK8—liver cancer	5.46e-06	0.000174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—liver cancer	5.44e-06	0.000174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CD—liver cancer	5.35e-06	0.000171	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—liver cancer	5.28e-06	0.000169	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—liver cancer	5.04e-06	0.000161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—STAT3—liver cancer	4.99e-06	0.000159	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CB—liver cancer	4.66e-06	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—liver cancer	4.64e-06	0.000148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—liver cancer	4.63e-06	0.000148	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—liver cancer	4.28e-06	0.000137	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—liver cancer	3.94e-06	0.000126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—liver cancer	3.81e-06	0.000122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HRAS—liver cancer	3.64e-06	0.000116	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—liver cancer	3.49e-06	0.000111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—liver cancer	3.22e-06	0.000103	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—liver cancer	2.84e-06	9.08e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—liver cancer	2.32e-06	7.42e-05	CbGpPWpGaD
